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Aims Abnormal Ca2þ release from the sarcoplasmic reticulum (SR), associated with Ca2þ-calmodulin kinase II (CaMKII)-
dependent phosphorylation of RyR2 at Ser2814, has consistently been linked to arrhythmogenesis and ischaemia/re-
perfusion (I/R)-induced cell death. In contrast, the role played by SR Ca2þ uptake under these stress conditions
remains controversial. We tested the hypothesis that an increase in SR Ca2þ uptake is able to attenuate reperfusion




We used WT mice, which have been previously shown to exhibit a transient increase in RyR2-Ser2814 phosphory-
lation at the onset of reperfusion; mice with constitutive pseudo-phosphorylation of RyR2 at Ser2814 (S2814D) to
exacerbate CaMKII-dependent reperfusion arrhythmias and cardiac damage, and phospholamban (PLN)-deficient-
S2814D knock-in (SDKO) mice resulting from crossbreeding S2814D with phospholamban knockout deficient
(PLNKO) mice. At baseline, S2814D and SDKO mice had structurally normal hearts. Moreover none of the strains
were arrhythmic before ischaemia. Upon cardiac I/R, WT, and S2814D hearts exhibited abundant arrhythmias that
were prevented by PLN ablation. In contrast, PLN ablation increased infarct size compared with WT and S2814D
hearts. Mechanistically, the enhanced SR Ca2þ sequestration evoked by PLN ablation in SDKO hearts prevented
arrhythmogenic events upon reperfusion by fragmenting SR Ca2þ waves into non-propagated and non-
arrhythmogenic events (mini-waves). Conversely, the increase in SR Ca2þ sequestration did not reduce but rather
exacerbated I/R-induced SR Ca2þ leak, as well as mitochondrial alterations, which were greatly avoided by inhibition
of RyR2. These results indicate that the increase in SR Ca2þ uptake is ineffective in preventing the enhanced SR
Ca2þ leak of PLN ablated myocytes from either entering into nearby mitochondria and/or activating additional
CaMKII pathways, contributing to cardiac damage.
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Conclusion Our results demonstrate that increasing SR Ca2þ uptake by PLN ablation can prevent the arrhythmic events trig-
gered by CaMKII-dependent phosphorylation of RyR2-induced SR Ca2þ leak. These findings underscore the benefits
of increasing SERCA2a activity in the face of SR Ca2þ triggered arrhythmias. However, enhanced SERCA2a cannot
prevent but rather exacerbates I/R cardiac injury.
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1. Introduction
Ischaemia/reperfusion (I/R) injury is one of the leading causes of heart
failure, cardiovascular disease, and sudden death in the western world.1
The consequences of cardiac ischaemia include reduced force produc-
tion, arrhythmias, and cell death. To limit these detrimental effects, re-
perfusion therapies are the standard treatment for patients suffering
myocardial infarction. However, re-establishing blood flow is usually
associated with additional cell damage, a phenomenon referred to as I/R
injury, exacerbating the effect of the preceding ischaemia. Indeed, it was
shown that reperfusion may trigger life-threatening arrhythmias and
accounts for up to half of the total I/R-induced infarct size.2–5
Although the factors contributing to I/R injury are complex, experi-
mental evidence reveals that loss of Ca2þ homeostasis is one of the ma-
jor contributing mechanisms.3,6–8 It has been established that at least one
of the signalling death pathways of this multifactorial injury involves
Ca2þ-calmodulin kinase II (CaMKII)—dependent phosphorylation RyR2-
Ser2814, mitochondrial Ca2þ overload through the mitochondrial Ca2þ
uniporter (MCU), cytochrome c release, and caspase-3 activation.3,9–11
Supporting and extending this signalling cascade, Joiner et al.12 showed
that CaMKII-dependent phosphorylation of MCU increases Ca2þ entry
into the mitochondria, favouring cell death.
In addition, alterations of RyR2 open probability have been associated
with ventricular arrhythmias in different pathologies. For instance, RyR2
mutation is one of the causes of catecholaminergic polymorphic ventric-
ular tachycardia (CPVT) and CaMKII-dependent phosphorylation of
RyR2 at Ser2814 has been associated with heart failure and reperfusion-
induced arrhythmias.4,13–15 Moreover, experimental evidence indicated
that animals with constitutive pseudo-phosphorylation at the RyR2-
Ser2814 site were more prone to stress-induced arrhythmias.16,17 The
increase in sarcoplasmic reticulum (SR) Ca2þ leak produced by RyR2
alterations, if high enough, may evoke SR Ca2þ waves and enhance Ca2þ
extrusion via the electrogenic Naþ/Ca2þ exchanger (NCX). This elec-
trogenic transport generates a depolarizing current, which—when suffi-
ciently large—leads to delayed afterdepolarizations (DADs) and
eventual triggering of ectopic action potentials (APs) and ventricular
arrhythmias.18,19
In contrast to the clear participation of CaMKII-dependent phosphor-
ylation of RyR2 on cardiac damage and ventricular arrhythmias during
I/R, the role of increasing SR Ca2þ uptake remains uncertain due to con-
troversial findings. Several studies support a beneficial effect of accelerat-
ing SR Ca2þ uptake in different pathologies, including experimental heart
failure,20–23 while others suggest a detrimental role.24–27 The cause for
these inconsistent findings may rest on the opposite effects that the aug-
mented SR Ca2þ uptake has on cytosolic Ca2þ. On one hand, increasing
the rate of SR Ca2þ reuptake would increase SR Ca2þ content, favouring
RyR2 Ca2þ sensitization, enhanced diastolic SR Ca2þ leak, and the con-
sequent risk of Ca2þ waves and mitochondria damage. On the other
hand, it would reduce cytosolic Ca2þ, and therefore, the risk of Ca2þ dif-
fusion throughout the cytosol and towards the mitochondria. Thus, a
slight imbalance between SR Ca2þ uptake and leak may favour either a
protective or a harmful outcome with opposite consequences on I/R
cardiac damage and arrhythmias. Another possibility that can indepen-
dently add variability to these complex outcomes, is the increase in
energy consumption that occurs as a consequence of the enhanced SR
Ca2þ uptake, which would conspire against post-ischaemic recovery as
previously shown in PLNKO mice.24
In the present study, we tested the hypothesis that an increase in SR
Ca2þ uptake produced by PLN ablation rescues the vulnerability to re-
perfusion arrhythmias and infarction, associated with RyR2 phosphoryla-
tion by CaMKII at Ser2814 and explored the underlying mechanisms. To
this purpose, we used hearts from WT mice, whose transient phosphor-
ylation of RyR2-Ser2814 at the onset of reperfusion is associated with
reperfusion cardiac damage (infarction) and arrhythmias7,28; hearts from
S2814D mice, with constitutive pseudo-phosphorylation of RyR2-
Ser2814,16 in an attempt to exacerbate the effects of RyR2-Ser2814
phosphorylation at the onset of I/R,4,9,11 and hearts from PLNKO and
SDKO mice, the latter resultant from crossbreeding PLNKO with
S2814D mice. The results indicate that our hypothesis holds true for re-
perfusion arrhythmias. However, ablation of PLN exacerbates cardiac in-
farct associated with Ser2814-RyR2 phosphorylation. These distinct
effects involved different sub-cellular mechanisms that were not related
to increases in energy demand.
2. Methods
An expanded Methods section is available in the Supplementary material
online.
2.1 Animals
Experiments were performed in 3–4-month-old male mice: PLN defi-
cient mice,29 RyR2-S2814D knock-in,16 and PLN deficient/RyR-S2814D,
resulting from crossbreeding PLNKO and RyR2-S2814D mice (SDKO
mice).17 C57BL/6 mice that constituted the background for PLNKO and
S2814D mice, were used as controls (WT mice). All experiments were
performed in accordance with the Guide for Care and Use of Laboratory
Animals (NIH Publication No.85-23, revised 2011) and approved by the
Ethics committee of the Faculty of Medicine, La Plata, Argentina
(CICUAL # P03-01-15).
2.2 Langendorff perfusion and
experimental protocol
Animals were anaesthetized with an intraperitoneal injection of keta-
mine/diazepam (100 mg/kg and 5 mg/kg, respectively). Central thoracot-
omy and heart excision were performed immediately after Phase III
anaesthesia was reached, verified by the loss of pedal withdrawal reflex.
Isolated hearts were perfused according to the Langendorff technique at
constant temperature (37C) and flow (2–3 mL/min), as previously de-
scribed.28,30 Hearts were subjected to a protocol of either 15 or 45 min

































































































of no-flow ischaemia followed by reperfusion, to assess reperfusion
arrhythmias,4 mechanical recovery, infarct size,9 lactate dehydrogenase
(LDH) release,9 and mitochondrial integrity.31
2.3 Histology
Cardiac wall, myocyte dimensions and interstitial fibrosis were assessed
in hearts from SDKO and WT mice. After paraffin embedding and sec-
tioning, samples were stained with haematoxylin-eosin for cell morphol-
ogy and with Picrosirius techniques for interstitial fibrosis, as previously
described.32
2.4 Western blot analysis
Cardiac homogenates were prepared as previously described.32 Protein
was measured by the Bradford method using BSA as standard. Lysates
were subjected to SDS-PAGE.33 After western blotting, membranes
were probed overnight with antibodies raised against total PLN
(Thermo Scientific MA3-922, Waltham, MA, USA), phosphor-Ser2814
(Badrilla A010-31, Leeds, UK), and total CaMKII (Badrilla A010-56AP,
Leeds, UK), total RyR2 (Thermo Scientific MA3-916, Waltham, MA,
USA), SERCA2a (Thermo Scientific MA3-919, Waltham, MA, USA), and
NCX (Millipore MAB1590, Burlington, MA, USA), and appropriate sec-
ondary antibodies. Glyceraldehyde phosphate dehydrogenase (GAPDH,
Millipore, MA, USA) was used as a loading control.
2.5 Echocardiographic examination
Baseline cardiac geometry and function were evaluated by two-dimen-
sional M-mode echocardiography, as previously described.17
2.6 Intracellular Ca2þ and APs
Rhod-2 and Di-8-ANEPPS (Invitrogen, USA) were used to assess intra-
cellular Ca2þ transients at the cytosol (Rhod-2) and transmembrane
APs, respectively. Measurements were performed at the epicardial layer
of intact mouse hearts using a custom-made setup for pulse local-field
fluorescence microscopy.34
2.7 Ca2þ sparks and waves in the intact
heart
Spontaneous local SR Ca2þ release was evaluated at the epicardial layer
of intact mouse hearts, as previously described, using Fluo-4 AM
(Invitrogen, OR, USA) and laser scanning confocal microscopy.6 A modi-
fied upright confocal microscope (OlympusFV 1000) with long-working
distance and high-numerical apertures (0.80/40x and 1.0/20x) objectives
was used for the fluorescence recordings. Both line scan recordings and
two-dimesional images were obtained from the left ventricular epilayer,
as previously described.6
2.8 Infarct size
After reperfusion, infarct size was assessed by the triphenyltetrazolium
chloride technique.9
2.9 LDH determination
Cardiac injury was also evaluated by LDH released in the perfusion efflu-
ent during the first 10 min of reperfusion.11
2.10 Cardiac energetics
The energetics of isolated mouse hearts were measured inside a flow-
calorimeter at 37C, as previously described,35 while perfusing them
with Krebs-2.5 mM Ca2þ at 1.5–2 mL/min.
2.11 Isolation and function of mouse
heart mitochondria
Two groups of mouse cardiac mitochondria were obtained. The first set
was isolated from perfused hearts that were not submitted to I/R (con-
trol mitochondria); the second set of mitochondria was isolated from
hearts submitted to I/R (15/10 min), after completion of the reperfusion
period. The perfused hearts were immediately washed and mitochondria
were obtained by differential centrifugation as previously described.31
Mitochondrial potential changes were evaluated by measuring
rhodamine-123 (RH-123, Sigma-Aldrich, St Louis, MO, USA) fluores-
cence quenching and mitochondrial swelling by light scattering.31
2.12 Statistics
Continuous variables were expressed as mean ± SEM and were evalu-
ated with either unpaired Student’s t-test or one or two-way ANOVA
followed by Tukey’s post hoc test, to compare differences among groups.
The Kruskal–Wallis test was used to compare differences among groups
with non-normal data distribution. Categorical data were expressed as
percentages and compared with Fisher’s exact test. A P-value <0.05 was
considered significant.
3. Results
3.1 SDKO mice exhibit a combined
functional phenotype of PLN ablation
and RyR2-S2814 phosphorylation
Knock-in mice in which aspartic acid replaces serine at RyR2-2814
(S2814D) to mimic constitutive phosphorylation of RyR2 by CaMKII
were crossbred with PLNKO. The resultant offspring (SDKO) did not
exhibit any significant structural difference when compared with WT
mice. On western blots, no significant alterations were observed in the
main proteins related to Ca2þ handling, but RyR2 expression was de-
creased by approximately 33% in agreement with previous findings17,29
(Supplementary material online, Figures S1 and S2).
The basal mechanical and Ca2þ handling characteristics of SDKO
hearts were also examined. Figure 1A–D shows the results of different
basal mechanical parameters of Langendorff perfused S2814D, SDKO,
PLNKO, and WT mouse hearts. In SDKO hearts, left ventricular devel-
oped pressure (LVDP) was similar to S2814D (Figure 1A). However,
maximal rate of rise of LVDP (þdP/dt) and maximal velocity of relaxation
(-dP/dt) (Figure 1B and C) were significantly higher than S2814D and WT
hearts and lower than PLNKO. Half relaxation time (t1=2) (Figure 1D), was
significantly shorter than in S2814D and WT but similar to PLNKO.
Figure 1E shows that the Ca2þ transient amplitude, measured at the epi-
cardial layer of the intact beating heart, was significantly higher in
PLNKO hearts than in the other three groups. Half relaxation time of
Ca2þ transient (Figure 1F) was significantly shorter in both the SDKO
and PLNKO compared with WT and S2814D hearts. Taken together,
these results indicate that SDKO hearts exhibit the combined functional
phenotype of PLNKO and S2814D hearts.
3.2 Reperfusion arrhythmias are not
exacerbated in S2814D mice
Previous experiments in WT hearts showed that auto-phosphorylation
of CaMKII and phosphorylation of RyR2-Ser2814 are significantly
increased by approximately two-fold at the onset of reperfusion
with respect to basal levels (pre-ischaemic).4,9 In those studies,



























..CaMKII-dependent phosphorylation of RyR2 was tightly associated to
reperfusion arrhythmias and cardiac damage.4,9 However, the observed
phosphorylation of RyR2-Ser2814 was transient, as it peaked between 1
and 3 min of reperfusion and then returned to pre-ischaemic values.36
Thus, we used homozygous S2814D mice, which have constitutively
phosphorylated Ser2814 in all four RyR2 subunits/channels,36 and are
more prone to stress-induced arrhythmias,16,17 to determine whether
this permanent pseudo-phosphorylation is associated with increased
propensity to reperfusion-induced arrhythmias compared with the tran-
sient phosphorylation in WT hearts.4,9 To that purpose, we subjected
WT and S2814D hearts to I/R (15/30 min) in the presence of blebbistatin
to minimize movement artefacts. Hearts were paced at 5 Hz during pre-
ischaemia. After 1 min of establishing no-flow ischaemia, stimulation was
stopped and the hearts beat spontaneously for the rest of the protocol.
Figure 2 presents a scheme of the experimental protocol (Figure 2A) and
shows typical examples (Figure 2B and C) of WT and S2814D hearts sub-
mitted to the I/R protocol. During reperfusion, spontaneous beats pre-
sented a similar occurrence in both WT and S2814D hearts. Left bars of
Figure 2E and F shows that both the incidence and frequency of sponta-
neous beats in S2814D hearts is not significantly different, when com-
pared with WT hearts. These results indicated that, in contrast to stress-
induced arrhythmias,17 S2814D hearts have a propensity to reperfusion
arrhythmias similar to WT mice. They also suggest that permanent
CaMKII-dependent phosphorylation of the S2814 in RyR2 does not en-
hance the proarrhyhtmic action associated with the transient increase in
S2814 phosphorylation of WT hearts at the onset of reperfusion.4
Possible explanations for these somewhat unexpected results are that:
(i) the transient but significant increase in CaMKII-dependent
Figure 1 Mechanical and Ca2þ transients parameters under basal conditions in the intact heart of the different strains studied. (A) LVDP was significantly
higher in PLNKO mice when compared with the other strains. (B and C) þdP/dt and relaxation rate (-dP/dt) were significantly increased in PLNKO and
SDKO mice vs. S2814D and WT hearts. (D) PLNKO and SDKO mice also showed a shorter half relaxation time (t1/2). (E) Cytosolic Ca
2þ transients at the
epicardial layer of the intact heart were significantly higher in PLNKO mice when compared with the other strains. (F) Relaxation of Ca2þ transient was
faster in PLNKO and SDKO, and slower in S2814D respect to WT hearts. Bars represent mean ± SEM. One-way ANOVA followed by Tukey’s post hoc
test, was used to compare different groups *P < 0.05 vs. WT, #P < 0.05 vs. S2814D, and &P < 0.05 vs. SDKO. N = 16–33 hearts in the different groups for me-
chanical data and 5–6 hearts in the different groups for cytosolic Ca2þ data.












































..phosphorylation of RyR2 in WT hearts at the onset of reperfusion is suf-
ficient to account for CaMKII-induced reperfusion arrhythmias; and (ii)
SR Ca2þ load at the beginning of reperfusion is lower in S2814D vs. WT
hearts. Indeed, this possibility is supported by previous experiments
showing that basal SR Ca2þ load was lower in S2814D than in WT iso-
lated myocytes16,17 (see Discussion below).
3.3 PLN ablation rescues reperfusion
arrhythmias typical of WTand S2814D
mouse hearts
We then tested the hypothesis that an increase in SR Ca2þ uptake, pro-
duced by PLN ablation rescues the vulnerability to reperfusion arrhyth-
mias associated with CaMKII phosphorylation of Ser2814-RyR2. To this
purpose, we subjected SDKO hearts to a protocol of 15/30 min I/R in
the presence of blebbistatin, as described above. The results of these
experiments are depicted in Figure 2D and the last bars of Figure 2E and F.
Ablation of PLN diminishes reperfusion arrhythmias observed in both
WT and S2814D hearts. As a proof of concept, we performed additional
experiments in SDKO hearts treated with 1mM of the SERCA2a inhibi-
tor cyclopiazonic acid (CPA), in an attempt to diminish SR Ca2þ uptake
and mimic S2814D (and WT) arrhythmic behaviour. Figure 2D shows the
results of one of these experiments (SDKO þ CPA). As expected, the
decrease in SR Ca2þ uptake by CPA, recapitulates the phenotype of
S2814D, i.e. reappearance of reperfusion arrhythmias. Overall results of
these experiments are shown in Figure 2E. Taken together, our findings
demonstrate that PLN ablation is capable of significantly diminishing
reperfusion-induced arrhythmias.
3.4 PLN ablation increased reperfusion
SR Ca2þ leak but rescued I/R-induced
Ca2þ waves
Next, we sought to elucidate the underlying mechanisms by which in-
creasing SR Ca2þ uptake by PLN ablation prevents reperfusion arrhyth-
mias. To that purpose, we use confocal microscopy to study
spontaneous Ca2þ release events in WT, S2814D, and SDKO hearts.
Hearts were stabilized and loaded with the calcium-sensitive fluorescent
dye under spontaneous beating and then submitted to 15/30 min I/R pro-
tocol in the presence of a combination of tetrodotoxin/carbamylcholine
and blebbistatin to minimize the intrinsic electrical activity of the heart
and cardiac movements, respectively (see Methods section). Figure 3A
displays typical examples of line scan recordings, showing epicardial
Ca2þ sparks obtained during reperfusion. Ca2þ sparks were more fre-
quent in WT and SDKO than in S2814D hearts. In several cases, as in
the example shown in Figure 3A for SDKO hearts, spontaneous Ca2þ
sparks can be visualized as clusters of high frequency events, reminiscent
of the repetitive releases at individual sites, described in these hearts by
Hüser et al.37 These in turn could trigger additional sparks in immediate
vicinity.37 Our findings are consistent with the enhanced SR Ca2þ uptake
and the reduced refractoriness of PLNKO hearts, similar to that of
SDKO, that we previously described.17 Figure 3B represents the binned
Figure 2 PLN ablation rescues the reperfusion ventricular arrhythmias produced by CaMKII-dependent phosphorylation of RyR2 at the S2814 site in the
intact heart. (A) Schematic representation of I/R protocol. (B–D) Representative action potential tracings during pre-ischaemia (left) and at the onset of re-
perfusion (right), in WT (B), S2814D (C), SDKO, and SDKO hearts in the absence and presence of CPA (D). Arrow in C indicates electrical stimulus artefact
on AP recording with microelectrodes. Arrowheads in C and D indicate premature beats. (E and F) Premature ventricular beat incidence and frequency
(box plot), respectively. Categorical data (E), expressed as percentages, were compared with Fisher’s exact test. Non-parametric data (F) were compared
with the Kruskal–Wallis test. A P-value <0.05 was considered significant. *P < 0.05 vs. WT and S2814D mice. N = 9–17 hearts in the different groups.





















histogram distribution of the kinetic characteristics of Ca2þ sparks in
SDKO hearts: full width at half maximum (FWHM) and full duration at
half maximum (FDHM). Superimposed for comparison are the curves
(in fuchsia) of the corresponding histograms of S2814D hearts, showing
a similar FWHM in SDKO and S2814D hearts, but a shorter FDHM in
SDKO vs. S2814D, consistent with a higher SR Ca2þ uptake and/or an in-
creased cytosolic Ca2þ buffering in the hearts of SDKO mice. Figure 3C
shows that Ca2þ spark frequency is significantly higher in SDKO than in
S2814D hearts. Figure 3D and E displays averaged Ca2þ spark mass
(calculated as spark amplitude * 1.206 * FWHM3)38 and the estimated
spark-mediated SR Ca2þ leak [defined as Ca2þ spark frequency (CaSpF)
* spark mass], respectively, which are higher in SDKO than in WT and
S2814D hearts. Figure 3 of supplementary information shows a scatter
plot indicating the variation in spark frequency, spark mass, and spark-
mediated Ca2þ leak in WT, S2814D, and SDKO hearts. The significantly
higher spark mass of SDKO vs. S2814D and WT hearts, would strongly
suggest a higher SR Ca2þ load in SDKO hearts, upon reperfusion.39
Moreover, the significantly lower Ca2þ spark frequency and spark mass
Figure 3 The frequency of epicardial Ca2þ sparks and SR Ca2þ leak at the onset of reperfusion is higher in SDKO than in WT and S2814D hearts. (A)
Typical examples of line scan recordings of epicardial Ca2þ sparks obtained in the intact hearts of WT, S2814D, and SDKO at the beginning (3 min) of reper-
fusion after 15 min of ischaemia. (B) Linear binned distribution of FWHM and log-binned distribution of FDHM of Ca2þ sparks of the intact SDKO hearts.
The corresponding curves of S2814D hearts are superimposed for comparison. FDHM was shorter in SDKO vs. S2814D. (C) Frequency of reperfusion
Ca2þ sparks in WT, S2814D, and SDKO intact hearts. (D and E) Mass of Ca2þ sparks and estimated spark-mediated SR Ca2þ leak in WT, S2814D, and
SDKO at the onset of reperfusion, respectively. Spark frequency at the onset of reperfusion was similar in SDKO than WT hearts and in both cases, higher
than in S2814D. Spark mass and spark-dependent RS Ca2þ leak were significantly higher in SDKO than in S2814D and WT hearts and lower in S2814D than
in WT hearts. Temperature: 32C. (C–E) Bars represent mean ± SEM. One-way ANOVA followed by Tukey’s post hoc test, was used to compare different
groups. A P-value <0.05 was considered significant. *P < 0.05 vs. WT mice, #P < 0.05 vs. S2814D. Data were obtained from 354, 318, and 281 events from
five different WT, S2814D, and SDKO hearts, respectively.






























..in S2814D mice vs. WT would support the idea that the non-stimulated
I/R protocol, used to visualize spontaneous events,6 further decreases
SR Ca2þ load with respect to WT hearts. Interestingly, although smaller,
SR Ca2þ leak in S2814D did not differ significantly from that of WT mice
(Figure 3C).
Figure 4A and B shows typical confocal images of Ca2þ waves obtained
during reperfusion in WT and SDKO. Whereas WT hearts presented
full Ca2þ waves upon reperfusion, SDKO showed only a few detectable
full propagating Ca2þ waves, despite severe spark-mediated SR Ca2þ
leak (Figure 3). In contrast, they presented uncompleted Ca2þ waves
(mini-waves). In some experiments, the spontaneous events appear as a
series of mini-events, like necklace beads (red arrows in the expanded
view of Figure 4B), conserving the shape of a wave, that finally fades out.
Figure 4C shows the overall results of the experiments. In reperfusion, SR
Ca2þ wave frequency was lower in SDKO vs. WT hearts. In contrast, ei-
ther fragmented waves or mini-waves prevailed over Ca2þ waves in
SDKO hearts. As a proof of concept, in four of the five experiments per-
formed in SDKO hearts, SERCA2a inhibitor CPA was added after 10 min
of reperfusion to diminish SR Ca2þ uptake. Notably, and similar to the
behaviour observed when measuring ventricular arrhythmias, Figure 4D
shows that SDKO hearts changed their typical mini-wave reperfusion
pattern after the addition of CPA (red arrows), showing full instead of
broken Ca2þ waves (right panel of Figure 4D). Similar results were
obtained in three additional experiments of this type. Supplementary
material online, Figure S4 shows additional examples of the interrupted
Ca2þ waves observed during reperfusion in both SDKO and PLNKO
hearts, which were transformed in non-fragmented Ca2þ waves in the
presence of CPA. In addition, Supplementary material online, Videos S1
and S2 show the different Ca2þ wave pattern elicited by reperfusion in
WT and SDKO hearts under confocal microscopy in the intact heart
(see also the time series confocal images). Taken together, the results
suggest that the enhancement of SR Ca2þ uptake, although able to
Figure 4 Epicardial Ca2þ waves at the onset of reperfusion are fragmented into non-propagated events in SDKO hearts. (A and B) Protocol and typical
examples of line scan recordings of epicardial Ca2þ waves obtained at the beginning of reperfusion in intact WT and SDKO hearts. (C) Frequency of Ca2þ
waves and mini-waves during pre-ischaemia and at the beginning of reperfusion in WT and SDKO hearts. (D) Protocol and typical recordings of line scan
before and after the addition of the SERCA2a inhibitor CPA in SDKO hearts. Red arrows in B and D indicate fragmented SR Ca2 waves. One-way ANOVA
followed by Tukey’s post hoc test, was used to compare different groups. A P-value <0.05 was considered significant. *P < 0.05 vs. WT mice, #P < 0.05 vs.
pre-ischaemia. Data are obtained from five WT and five SDKO hearts.

































































































persistently produce spontaneous Ca2þ events, averts Ca2þ wave prop-
agation and transforms Ca2þ waves into fragmented, non-entire cell
propagated SR Ca2þ release events.
3.5 PLN ablation exacerbates the damage
produced by I/R in S2814D hearts
Previous experiments showed that when Ser2814D hearts were sub-
jected to a protocol of I/R (45/120 min), there was a significant increase
in infarct size and HDL release with respect to WT mice. Moreover, pre-
vention of S2814 phosphorylation diminished I/R injury, i.e. necrotic and
apoptotic death, and improved functional recovery in the intact heart.9
Thus, the following series of experiments was designed to test whether
ablation of PLN could prevent I/R cardiac damage, induced by RyR2-
Ser2814 phosphorylation at the onset of reperfusion. To this purpose,
SDKO, PLNKO, S2814D, and WT hearts were subjected to two differ-
ent protocols of I/R: 45/120 and 15/30 min. In both protocols, hearts
were paced at 5 Hz during pre-ischaemia and reperfusion. Stimulation
was stopped during the ischaemic period, after 1 min of cessation of cor-
onary flow.7,28,30 Supplementary material online, Figure S5A and B shows
that whereas left ventricular end diastolic pressure was similarly affected
in the four groups of hearts, the prolonged ischaemic period (45 min) did
not affect LVDP in S2814D relative to WT hearts, in agreement with
previous findings.9 However, LVDP was greatly diminished in PLNKO
and SDKO hearts vs. WT, in consonance with previous findings in
PLNKO hearts.24 Similarly, infarct size and LDH release during reperfu-
sion were significantly greater in SDKO and PLNKO hearts
compared with WT and S2814D (Supplementary material online, Figure
S5C and D).
Since the long I/R protocol produced an almost null mechanical recov-
ery and an infarct of nearly 70% of the total risk area in SDKO and
PLNKO hearts, we explored the effect of a shorter I/R period (15/
30 min) in an attempt to uncover any potential differences between
PLNKO and SDKO hearts. The ischaemic period of 15 min was chosen
because it is known to produce a reversible functional injury, without
structural cardiac damage in WT (control) hearts.40,41 Figure 5 shows the
results of this group of experiments. Whereas the mechanical recovery
was similar between WT and S2814D hearts, it was significantly lower in
SDKO hearts (Figure 5A and B). The infarct size was not significant in WT
and S2814D hearts; the 5–10% infarct of these hearts (arrows) mostly
corresponds to the damage produced by stimulation electrodes. In con-
trast, infarct size significantly increased in PLNKO and SDKO hearts.
Notably, the infarct size and LDH release were significantly higher in
SDKO than in PLNKO hearts (Figure 5C and D). It is important to note
that S2814D hearts suffered a significantly higher infarct size than WT
hearts only when submitted to the prolonged I/R protocol
(Supplementary material online, Figure S5). These findings suggest that
the permanent phosphorylation of Ser2814, which should be associated
with a constant increased SR Ca2þ leak during the whole I/R period,
increases cardiac injury over that produced by the transient phosphory-
lation of S2814 in WT at the onset of reperfusion. In addition, our results
indicate that the increase in SR Ca2þ reuptake produced by PLN
ablation is unable to rescue the damage evoked by I/R in WT and
S2814D hearts. On the contrary, cardiac injury was even higher in
SDKO hearts than in all other groups, including PLNKO. An additional
finding of these experiments is that the mechanical recovery tended to
be dissociated from the structural damage in S2814D and SDKO hearts,
when compared with WT and PLNKO hearts, at least within the first
30 min of reperfusion. Although we did not explore the reason for this
uncoupling, a possible explanation may lie in the opposite effects of
CaMKII-dependent phosphorylation at RyR2-Ser2814 site: an increase in
fractional Ca2þ release, which would contribute to support LVDP42 and
an enhancement of SR Ca2þ leak, which would possibly exacerbate car-
diac damage.16,17
3.6 The enhanced cardiac damage of SDKO
vs. S2814D hearts is associated with
mitochondrial dysfunction but not with
augmented energy consumption
Several possible explanations can account for the higher damage pro-
duced by I/R in SDKO hearts vs. S2814D hearts. Previous experiments
indicated that PLNKO hearts are more vulnerable to I/R injury due to
the high energy cost inherent to the enhanced Ca2þ turnover and in-
creased contractility typical of PLN ablation.24 Thus, the higher energy
consumption in SDKO mice, associated with PLN ablation, could explain
the observed difference.
To assess whether energy metabolism is altered, we measured the en-
ergetic demand in all four groups of hearts submitted to a protocol of
15/30 min I/R, as the one used to measure infarct size and cardiac me-
chanics. Hearts were paced at 5 Hz during pre-ischaemia and reperfusion
and stimulation was stopped after one minute of flow cessation during
the ischaemic period. As shown in Supplementary material online, Figure
S6, the pre-ischaemic total heat production (Ht), was similar in SDKO,
PLNKO, and S2814D and in all cases greater than in WT hearts. These
results suggest that the higher reperfusion damage, observed in SDKO
vs. S2814D hearts, cannot be attributed to a higher energetic demand in
SDKO hearts vs. S2814D. Moreover, total Ht in SDKO hearts was lower
than in PLNKO during the protocol of I/R, consistent with the higher in-
farct size and mitochondria dysfunction of double mutant hearts (see
Figures 5D and 6B, C ).
A second possible explanation that may account for the higher dam-
age, observed during I/R in SDKO hearts, is the increased in SR Ca2þ
leak exhibited in SDKO described above (Figure 3). If the increase in SR
Ca2þ leak is involved in the bigger infarct size of SDKO mice, it is reason-
able to expect a more prominent mitochondrial dysfunction produced
by mitochondrial Ca2þ overload in SDKO than in S2814D and WT
hearts, which in turn might be circumvented by inhibiting SR Ca2þ leak.
To test this hypothesis, we evaluated mitochondrial state in isolated mi-
tochondria, obtained from the four different groups of hearts that were
submitted to a protocol of I/R (15/10 min) and paced during pre-ischae-
mia and reperfusion (stimulation was halted after 1 min of ischaemia).
Figure 6B shows the overall results of mitochondrial membrane potential
(DWm; expressed in mV) of S2814D and SDKO mitochondria under
basal conditions (i.e. pre-ischaemia, upper panel) and after the protocol
of I/R (i.e. reperfusion, lower panel). Overall results obtained from WT
and PLNKO are shown for comparison. The insets in the Figure display
typical traces of rhodamine fluorescence changes (DF) expressed in arbi-
trary units, used for DWm determinations in mitochondria isolated from
S2814D and SDKO hearts previously submitted to I/R. Under basal con-
ditions, there is no significant difference in DWm among the different
groups. In contrast, the short protocol of I/R significantly increased mito-
chondrial depolarization in SDKO vs. the other groups, including
PLNKO mitochondria. Figure 6C shows typical examples and overall
results of mitochondria swelling, measured as light scattering decrease
(LSD), in samples derived from the four groups of hearts after addition
of 50mM Ca2þ. In mitochondria, which were not submitted to I/R (basal
conditions), the LSD produced by the addition of Ca2þ was significantly






























..lower in S2814D, SDKO, and PLNKO than in WT, suggesting that mito-
chondria from these groups are initially more loaded with Ca2þ than
WT mitochondria. In mitochondria submitted to the modest I/R chal-
lenge, LSD produced by addition of Ca2þ was not significantly different
in S2814D and PLNKO, when compared with WT mitochondria.
However, LSD was significantly lower in SDKO mitochondria vs. all
groups. Figure 6D shows a tight negative correlation between mitochon-
drial swelling and DWm. Of note, comparison of the LSD and DWm
alterations of the four groups, shows that they followed a similar pattern
to that observed when infarct size and LDH release were explored
(Figure 6D and E), i.e. infarct size increases as mitochondrial damage
increases (Figure 6E). Taken together, the results indicate that mitochon-
drial damage is significantly more important in SDKO than in S2814D
hearts. Moreover, in the presence of 5mM dantrolene, used to inhibit
RyR2, mitochondrial damage was significantly prevented (last bars of
bottom panel of Figure 6A and B). These results support the idea that the
greater SR Ca2þ leak of SDKO hearts is significantly involved in the en-
hanced cardiac damage produced by I/R in these hearts.
Taken together, the present findings indicate that increased SR Ca2þ
uptake is able to interfere and impair cytosolic Ca2þ wave propagation,
produced by the enhanced SR Ca2þ leak, but ineffective in preventing
the increased Ca2þ flux from the SR to the cytosol, particularly to the
neighbouring mitochondria.
4. Discussion
The key finding of the present study is that PLN ablation reduces
the propensity to reperfusion arrhythmias evoked by CaMKII-
dependent phosphorylation of RyR2-Ser2814 in the intact heart.
The clinical relevance of these findings is obviously significant with
respect to reperfusion arrhythmias as well as to arrhythmias in
Figure 5 PLN ablation produces mechanical dysfunction and cardiac damage in S2814D hearts submitted to short-term I/R. (A) Experimental protocol.
LDH indicates the time period of samples recollection for LDH measurements. Head arrow indicates the time point of infarct determination. (B and C) Mice
with dual mutation (SDKO) had a slightly better mechanical recovery compared to PLNKO but both groups had a significantly greater deterioration with re-
spect to WT and S2814D mice. (D and E) After short-term ischaemia, SDKO hearts have the larger infarct area and the highest LDH release in reperfusion,
compared with the other groups. Of note, in S2814D infarct size and LDH release were not different from values in WT hearts. Arrows indicate the dam-
aged area, mostly corresponding to the insertion of stimulation electrodes. One-way ANOVA followed by Tukey’s post hoc test, was used to compare differ-
ent groups. A P-value <0.05 was considered significant. *P < 0.05 vs. WT mice, #P < 0.05 vs. S2814D,̂ P < 0.05 vs. SDKO, &P < 0.05 vs. PLNKO, and †P < 0.05
vs. the corresponding pre-ischaemic values (Paired t-test). N = 5–9 hearts in the different groups.


















failing hearts, since CaMKII expression, activity, and phosphoryla-
tion of RyR2 at S2814 are all enhanced in patients and animals
with HF,14,43 as well as during reperfusion after cardiac
ischaemia.9,11,30 However, PLN ablation fails to rescue the in-
creased propensity to infarct size produced by this phosphoryla-
tion. Quite the opposite, it exacerbates cardiac reperfusion
damage, i.e. infarct size and LDH release. This occurred not only
when hearts were submitted to a long ischaemic period, but also
after short ischaemia, which does not produce significant cardiac
damage upon reperfusion in WT and S2814D mutant hearts.
The inconsistency between the reduced propensity to reperfusion
arrhythmias and the worsening of reperfusion cardiac damage when in-
creasing SR Ca2þ uptake, suggests different mechanisms involved in
these two processes.
Figure 6 The enhanced cardiac damage of SDKO hearts is associated with mitochondrial dysfunction. (A) Experimental protocol. (B) Typical rhodamine
fluorescence changes, expressed in arbitrary units (a.u.), in mitochondrial isolated from perfused (upper panel) and ischaemic-reperfused (lower panel)
hearts of S2814D and SDKO hearts, and mean values of mitochondrial membrane potential (DWm, mV) in all groups (WT, S2814D, PLNKO, and SDKO).
(C) Typical traces of light scattering after the addition of 50lM Ca2þ to mitochondrial samples isolated from perfused hearts (upper panel) and ischaemic-
reperfused hearts (lower panel) of S2814D and SDKO hearts, and mean values of LSD in mitochondrial samples from all groups. (C) Correlation between
LSD and DWm. (D) Correlation between infarct size and DWm. One-way ANOVA followed by Tukey’s post hoc test, was used to compare different groups.
A P-value <0.05 was considered significant. *P < 0.05 vs. WT, #P < 0.05 vs. SDKO, and &P < 0.05 vs. SDKO þ dantrolene. N = 5–9 hearts in the different
groups.

































































































4.1 Constitutive pseudo-phosphorylation of
S2814D did not exacerbate reperfusion
arrhythmias
It was previously shown that the arrhythmic pattern, observed during
the early reperfusion period, can be traced to ectopic sources, i.e. early
reperfusion arrhythmias were triggered by both DADs and EADs.4,44,45
It was further shown that a main cause of the reperfusion arrhythmo-
genic behaviour is an increase in the phosphorylation of the RyR2-
Ser2814 site at the onset of reperfusion. Mutation of this site to the
non-phosphorylatable form (S2814A) critically diminished reperfusion
arrhythmias.4 Thus, at first sight, the failure of S2814D to significantly in-
crease reperfusion arrhythmias over those observed in WT hearts might
appear unexpected. Indeed, previous results demonstrated that S2814D
mice are more prone to stress-induced arrhythmias than WT mice.16,17
One can argue that the transient phosphorylation of WT mice at the on-
set of reperfusion, may account by itself for reperfusion arrhythmias, i.e.
the ‘permanent RyR2 phosphorylation’ of S2814D would not add any
significant influence on reperfusion arrhythmias. However, previous
experiments indicated that SR Ca2þ load is significantly lower in S2814D
than in WT myocytes under basal conditions. Indeed S2814D was
shown to be more prone to arrhythmias only under stress situations,
like b-adrenergic stimulation, increasing extracellular Ca2þ or stimula-
tion frequency, all conditions known to enhance SR Ca2þ load.16,17 The
lower SR Ca2þ content in association with the ‘permanent CaMKII-
dependent phosphorylation’ of the Ser2814 site, may account for the
similarity in reperfusion arrhythmic patterns presented by S2814D and
WT hearts. The SR Ca2þ load of S2814D should be still lower, when
compared with WT, when non-stimulated protocols were used to de-
tect spontaneous events. Under these conditions, assessment of SR
Ca2þ spark mass and frequency strongly indicate that SR Ca2þ content
was significantly lower in S2814D than in WT mice at the beginning of
reperfusion (Figure 3).
4.2 SR Ca2þ waves are the substrate of
reperfusion arrhythmias
Reperfusion significantly increases SR Ca2þwave frequency relative to is-
chaemia and pre-ischaemia6 and these reperfusion Ca2þ waves might
constitute the substrate of reperfusion arrhythmias. The fact that in the
present experiments SR Ca2þ waves were associated with reperfusion
arrhythmias and that abortion of SR Ca2þ waves by PLN ablation
concurrently decreased reperfusion arrhythmias, further confirmed this
concept. Moreover, decreasing SR Ca2þ uptake by inhibiting SERCA2a
in PLN ablated hearts, recapitulated the arrhythmogenic phenotype of
WT and S2814D hearts. SR Ca2þ waves would lead to enhanced Ca2þ
extrusion via the electrogenic NCX, generating a depolarizing current
(transient inward current), which, when sufficiently large, leads to DADs
and potentially triggers ectopic APs and ventricular arrhythmias.18,19
4.3 PLN ablation prevents reperfusion
arrhythmias by aborting fully propagated
SR Ca2þ waves
PLN ablation severely enhanced reperfusion SR Ca2þ leak in SDKO
hearts. Paradoxically, SR Ca2þ waves were significantly reduced. An
increase in SR Ca2þ leak associated with a decrease in Ca2þ waves indi-
cates a limitation in Ca2þ wave propagation throughout the cytosol.
Indeed, our findings clearly show that PLN ablation interrupts cell-length
propagating Ca2þ waves, switching them into non-propagated events,
like mini-waves. Thus, these results support the conclusion that PLN ab-
lation increases Ca2þ buffer capacity by decreasing cytosolic Ca2þ and
hampers Ca2þ wave propagation resulting in silencing of arrhythmias.
Further support to this idea is provided by the experiments in which the
SERCA2a inhibitor, CPA, converts non-propagating mini-waves into full
propagating Ca2þwaves.
4.4 PLN ablation further increases
I/R –induced cardiac damage
In contrast to the beneficial effects on reperfusion arrhythmias, PLN ab-
lation failed to decrease cardiac damage. On the contrary, it exacerbated
infarct size and LDH release. The increase in infarct size associated with
higher mitochondria damage, observed in SDKO with respect to WT
and S2814D hearts, reveals that the enhanced SR Ca2þ uptake by PLN
ablation is not capable of preventing the increase in infarct size associ-
ated with CaMKII-dependent phosphorylation of RyR2-Ser2814. It also
uncovers that ablation of PLN would trigger additional mechanisms re-
sponsible for enhanced cardiac damage.
Previous experiments indicated that when SR Ca2þ reuptake is highly
augmented by ablation of PLN, post-ischaemic recovery of contractile
function was significantly reduced and cardiac infarct size was in-
creased.24 These experiments suggested that the higher ATP consump-
tion of PLNKO hyperactive hearts relative to WTs is the main cause for
the increased damage of these hearts.24 In this study, we found that pre-
ischaemic total Ht was similar in SDKO and S2814D hearts, making it dif-
ficult to attribute the enhanced cardiac damage of SDKO to higher
energy consumption in the double mutant hearts. The increased cardiac
injury produced by PLN ablation may be at least partially linked to the
concomitant loss of HAX-1 from the SR, which may result in increased
ER stress and mitochondrial damage. Indeed, it has been recently shown
that PLN binds to the anti-apoptotic protein HAX-1 in cardiomyocytes
and HAX-1 appears to confer protection from I/R injury.46,47 These pro-
apoptotic actions of PLN ablation may partially explain the increase in
heart damage of SDKO vs. S2814D and WT hearts. In addition, our
results clearly showed that cardiac injury and mitochondrial dysfunction
were significantly enhanced in SDKO, when compared to PLNKO hearts
(Figures 5 and 6). The greater damage suffered by SDKO vs. PLNKO
hearts could be explained by a mechanism linking their unique situation
of augmented SR Ca2þ uptake in the presence of a permanent RyR2
Ca2þ leak. Under conditions in which RyR2 are leaky, a persistent and
exacerbated SR Ca2þ uptake, would greatly enhance the propensity for
SR Ca2þ leak, which may conspire against contractile recovery produc-
ing instead, cardiac damage. Indeed, mitochondrial dysfunction could be
prevented in SDKO hearts submitted to I/R, when SR Ca2þ leak was
inhibited by dantrolene. It could be argued that dantrolene, being a
somewhat selective inhibitor of RyR1 may be mediating its protective
effects by inhibiting mitochondrial RyR1 rather than SR RyR2. Indeed, it
has been shown that stimulation of IP3 receptors with endothelin-1
induces Ca2þ release from the SR and increases mitochondrial Ca2þ via
mitochondrial RyR1 rather than RyR2.48 Since reperfusion after ischae-
mia produced a rapid and transient release of inositol phosphates,49 the
possibility of an increase in Ca2þ release through IP3 receptors cannot
be excluded. However, biochemical and functional evidence indicates
that dantrolene targets a corresponding region of RyR250 and that it
effectively affects RyR2-mediated Ca2þ-dependent processes under par-
ticular stress conditions like I/R injury, CPVT, or CaMKII-dependent
arrhythmias.51–54 Moreover, previous results from our own laboratory
indicated that inhibiting RyR2 with 1mM tetracaine, also diminished cell






























































































..death produced by I/R55 and that Ru360, used to inhibit the permeability
transition pore MCU, decreases infarct size and cell death evoked by
I/R,11 strongly suggesting that the main Ca2þ mitochondria influx in I/R
occurs through the MCU rather than mitochondrial RyR1. Additionally,
it is reasonable to expect that a reperfusion-induced mitochondrial dam-
age, exclusively mediated by IP3 release, would cause a similar or higher
cardiac damage in PLNKO (with a higher SR Ca2þ content) than in
SDKO hearts, which is not the case of the present experiments. Taken
together, and considering that we are dealing with RyR2 leaky hearts,16,17
our results support the conclusion that cardiac damage and mitochon-
drial dysfunction in SDKO hearts mainly occurs through the release of
Ca2þ from RyR2. Since it has been shown that IP3 release could facilitate
RyR2 activity,56 it is tempting to speculate that a possible IP3 release
upon reperfusion in our experiments would contribute to the detrimen-
tal mitochondrial effect of RyR2 leak in SDKO hearts. In any case, our
results indicate that the failure of the increased SR Ca2þ reuptake to pre-
vent cardiac injury is associated with the inability of this mechanism to
prevent mitochondria damage, as revealed by the close correlation be-
tween mitochondria dysfunction and infarct size in the different strains
(Figure 6E). The higher mitochondria injury, associated with the en-
hanced SR Ca2þ leak, may be favoured by the close spatial proximity of
mitochondria and SR Ca2þ release sites, which would greatly increase
the local Ca2þ at the interphase between both organelles,57 impeding
the beneficial effect of the increase SR Ca2þ uptake. Moreover, the in-
creased SR Ca2þ leak may activate additional CaMKII-dependent delete-
rious pathways which could also play a role in the enhanced cardiac
damage observed.58,59
4.5 Limitations of the study
We are aware of the limitations that animal models present regarding
findings on arrhythmias, infarct size, or mitochondrial damage compared
with patients. Therefore, any extrapolation of the present findings to the
clinical scenario should be made with caution. In particular, referent to
the mitochondrial function experiments, the fact that determinations
were made in isolated mitochondria about half an hour after the end of
reperfusion (which is the required time period for isolation), and that mi-
tochondria were exposed to a standard buffer, might have affected the
results. However, we consider that conclusions are still valid, taking into
account that: (i) All models were submitted to the same procedure; (ii)
There were not significant differences among groups in mitochondria
membrane potential from hearts not submitted to I/R; (iii) The basal mi-
tochondria membrane potential obtained (hearts not submitted to I/R)
was about -160 mV, in close relation with reports assessing mitochondria
membrane potential with different techniques59; (iv) There was a signifi-
cant decrease in light scattering in mitochondria from S2814D, SDKO,
and PLNKO vs. WT in hearts non subjected to I/R, clearly suggesting an
increase in mitochondria Ca2þ, which should be expected from the
increased SR Ca2þ leak of these mutant hearts; and (v) Significant differ-
ences were detected among the different models after hearts were sub-
mitted to the I/R protocol, in agreement with our hypothesis.
Furthermore, we recognize that the use of TTX and carbamylcholine
could have altered the clinical situation present during I/R. However, it
have been shown that both interventions are cardioprotective.60,61
Thus, the use of these drugs in the present experiments would have
tended to decrease, if any, the magnitude of our observations in all four
groups studied. Moreover, although a recent paper suggests that the me-
chanical uncoupler blebbistatin, increases AP duration and ventricular
fibrillation threshold in perfused rabbit heart,62 several other studies
showed that the drug has no significant cardiac electrophysiological
effects in a number of species, including mouse cardiac tissue.63–65 These
results suggest that the use of the drug could have hardly affected our
results.
Finally, in the present experiments, we calculated spark-mediated SR
Ca2þ leak. However, previous measurements in isolated myocytes
showed that RyR2 mediated Ca2þ leak has a second component not
mediated by Ca2þ sparks that should be added to the spark-mediated
Ca2þ leak to estimate total RyR2-mediated Ca2þ leak.38 Although the
underlying mechanisms of non-spark mediated Ca2þ leak are not
completely elucidated, experimental evidence support the concept that,
similar to spark-dependent leak, non-spark mediated Ca2þ leak depend
on both, SR Ca2þ load and RyR2 sensitization.38 It is, therefore, difficult
to expect a higher increase in non-spark mediated Ca2þ leak in S2814D
and WT than in SDKO hearts, of such a magnitude that could offset the
difference in spark-mediated Ca2þ leak that we observed among them
(Figure 3).
In conclusion, our experiments revealed for the first time the opposite
roles of increased SR Ca2þ uptake on I/R-induced arrhythmias and car-
diac damage and dissected the mechanisms by which these two different
effects take place. Whereas the enhanced SR Ca2þ uptake was able to
eliminate the propagation of Ca2þ waves, elicited by the exacerbated SR
Ca2þ leak of SDKO hearts, it was inefficient to impede the flow of this
SR Ca2þ leak to the mitochondria and/or activation of other CaMKII del-
eterious pathways, aggravating cardiac damage.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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